Access to needed medication should be ensured, including pharmacological substitution and maintenance therapy, as well as access to comprehensive interventions that cover clients’ complex biological, psychological, and social needs. (See Annex 3.)
- Access to controlled medicines
- Harm reduction
In May 2013, the Organization of American States released two groundbreaking reports – an analytical and a scenarios report, promoting a balanced approach toward drug control, including the provision of harm reduction, the decriminalisation of people who use drugs, and the need to experiment with innovative drug policies, including regulatory regimes.